CAS: 61924-25-2; 1-(Isocyanatomethyl)-3-Methylbenzene

该化合物是一种有机化合物,其特征是附于3-甲基苯基甲酸酯的异丙氰酸酯功能组(-N=C=O),该化合物一般是无色的黄色液体,具有刺眼的气味;以其反应性而闻名,尤其是通过酒精和胺反应形成聚氨酯和尿素衍生物;异丙酸酯组的存在使该化合物成为有机合成的多种中间体,特别是在生产各种药品,农用化学品和聚合物时. 3-甲基苯基异丙酸酯也因其潜在的健康危害而得到承认;它可能会刺激皮肤,眼睛和呼吸系统,需要在实验室和工业环境中谨慎地处理和采取适当的安全措施;此外,必须指出,该化合物应储存在一个冷,干燥的地方,远离不相容的材料,防止降解或危险反应.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号32315-10-9 三光气 | CAS号100-81-2 间甲基苄胺 | CAS号621-36-3 间甲苯乙酸 | CAS号13910-79-7 间甲苯乙酰氯

合成工艺路线路线简述

  • 合成目标产物 3-Methylbenzyl Isocyanate 主要起始原料 3-Methylphenylacetic Acid
  • (文献来源)合成步骤主要原料 3-Methylphenylacetic Acid
3-甲基苯乙酸置于sodium Azide,草酰氯,N,N-二甲基甲酰胺体系中,用 二氯甲烷,氯仿,水,丙酮 作为反应溶剂,化学反应 1.42H,反应生成 3-甲基苄基异氰酸酯
参考文献:Orally Active .Beta.-Lactam Inhibitors Of Human Leukocyte Elastase-1. Activity Of 3,3-Diethyl-2-Azetidinones
标题:Orally Active .Beta.-Lactam Inhibitors Of Human Leukocyte Elastase-1. Activity Of 3,3-Diethyl-2-Azetidinones
摘要:A Thorough Analysis Of The Mechanism Of Inhibition Of Human Leukocyte Elastase (Hle) By A Monocyclic Beta-Lactam And The Mechanism Of Beta-Lactam Hydrolysis Led To The Preparation Of Potent And Highly Stable Inhibitors Of Hle. This Work Led To The Identification Of 4-[(4-Carboxyphenyl)-Oxy]-3,3-Diethyl-1-[[(Phenylmethyl)Amino]Carbonyl]-2-Azetidinone (2) As The First Orally Active Inhibitor Of Human Leukocyte Elastase (Hle). Analogs Of 2 With Different Substituents On The Urea N Were Synthesized And Evaluated For Their Activity In Vitro Against Hle As Well As In Vivo In A Hamster Lung Hemorrhage Model. Compounds With A Methyl Or A Methoxy Group In The Para Position Of The Benzene Ring Were Very Potent In Both Assays. The Results Are Discussed On The Basis Of The Proposed Model For The Binding Of This Class Of Inhibitors To Hle And A Possible Mechanism Of Inhibition Is Presented.
DOI:10.1021/jm00099A003

海关参考信息

专利信息


专利号:US-9833457-B2
优先权日:2008-01-25
标题:Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
发明人:MJALLI ADNAN M M; GADDAM BAPU; POLISETTI DHARMA RAO; KOSTURA MATTHEW J; GUZEL MUSTAFA
权利人:VTV THERAPEUTICS LLC
摘要:The present invention relates to chemical compounds of Formula (I) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of conditions or disorders mediated by TNF-α or by PDE4, including but not limited to psoriatic arthritis.

专利号:WO-2009094528-A1
优先权日:2008-01-25
标 题:TRICYCLIC COMPOUNDS AS MODULATORS OF TNF-α SYNTHESIS AND AS PDE4 INHIBITORS

专利号:US-2012172381-A1
优先权日:2008-01-25
标题 :Tricyclic Compounds as Modulators of TNF-alpha Synthesis and as PDE4 Inhibitors

专利号:US-2018071297-A1
优先权日:2008-01-25
标题 :Tricyclic compounds as modulators of tnf-alpha synthesis and as pde4 inhibitors

专利号:US-2011160234-A1
优先权日:2008-01-25
标题 :Tricyclic Compounds as Modulators of TNF-alpha Synthesis and as PDE4 Inhibitors

专利号:US-9393245-B2
优先权日:2008-01-25
标 题:Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
河南氢硅新材料科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.qgxcl.com
企业联系电话:18569915792(微信号15038032370);18039286726(微信同号)👤
📞河南氢硅新材料科技有限公司 ⚠️参考联系方式

电话:18569915792(微信号15038032370);18039286726(微信同号)


邮箱:qingguixincailiao@163.com
通信地址: 河南省焦作市沁阳市沁园街道未来路1号
邮编: 454550
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:河南省焦作市沁阳市沁园街道未来路1号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/bf01527220
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知